Compare DDOG & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DDOG | A |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5B | 39.8B |
| IPO Year | 2019 | 1999 |
| Metric | DDOG | A |
|---|---|---|
| Price | $146.42 | $139.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 33 | 15 |
| Target Price | ★ $192.06 | $162.80 |
| AVG Volume (30 Days) | ★ 4.1M | 2.1M |
| Earning Date | 11-06-2025 | 11-24-2025 |
| Dividend Yield | N/A | ★ 0.73% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | 0.31 | ★ 4.57 |
| Revenue | $3,211,691,000.00 | ★ $6,948,000,000.00 |
| Revenue This Year | $28.86 | $7.76 |
| Revenue Next Year | $20.99 | $6.24 |
| P/E Ratio | $471.22 | ★ $30.56 |
| Revenue Growth | ★ 26.63 | 6.73 |
| 52 Week Low | $81.63 | $96.43 |
| 52 Week High | $201.69 | $160.27 |
| Indicator | DDOG | A |
|---|---|---|
| Relative Strength Index (RSI) | 32.68 | 38.14 |
| Support Level | $150.08 | $140.22 |
| Resistance Level | $156.10 | $143.93 |
| Average True Range (ATR) | 3.77 | 3.88 |
| MACD | -1.70 | -1.45 |
| Stochastic Oscillator | 4.47 | 1.14 |
Datadog is a cloud-native company that focuses on analyzing machine data. The firm's product portfolio, delivered via software as a service, enables clients to monitor and analyze their entire information technology infrastructure, from servers to applications and Python scripts. Datadog's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to utilize it for a variety of applications throughout their businesses to ensure uptime and latency objectives.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.